Your browser doesn't support javascript.
loading
'Off-the-shelf' allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignancies.
Sinha, Debottam; Srihari, Sriganesh; Beckett, Kirrliee; Le Texier, Laetitia; Solomon, Matthew; Panikkar, Archana; Ambalathingal, George R; Lekieffre, Lea; Crooks, Pauline; Rehan, Sweera; Neller, Michelle A; Smith, Corey; Khanna, Rajiv.
Afiliación
  • Sinha D; Immunology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Srihari S; Immunology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Beckett K; Immunology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Le Texier L; Immunology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Solomon M; Immunology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Panikkar A; Immunology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Ambalathingal GR; Immunology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Lekieffre L; Immunology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Crooks P; Immunology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Rehan S; Immunology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Neller MA; Immunology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Smith C; Immunology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Khanna R; Immunology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia rajiv.khanna@qimr.edu.au.
J Immunother Cancer ; 9(2)2021 02.
Article en En | MEDLINE | ID: mdl-33589524
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T / Proteínas de la Matriz Viral / Herpesvirus Humano 4 / Antígenos Nucleares del Virus de Epstein-Barr / Infecciones por Virus de Epstein-Barr / Inhibidores de Puntos de Control Inmunológico / Linfoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T / Proteínas de la Matriz Viral / Herpesvirus Humano 4 / Antígenos Nucleares del Virus de Epstein-Barr / Infecciones por Virus de Epstein-Barr / Inhibidores de Puntos de Control Inmunológico / Linfoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Australia